Likang Xiangyun Biotechnology Co., Ltd. is a high-tech enterprise specializing in the R&D, production, and global distribution of innovative medical devices and IVD (in vitro diagnostic) solutions. Established in 1995 and headquartered in Urumqi, China, we leverage 30+ years of expertise to deliver cutting-edge cardiovascular interventional products, biochemical reagents, and medical equipment, serving over 150 healthcare institutions worldwide.
As a key player in China’s Belt and Road Initiative, we integrate R&D, manufacturing, and cross-border trade, with certifications including CE, ISO13485, and MDR. Our 20,000m² industrial park in Xinjiang’s Khorgos Economic Zone enables efficient logistics to markets in Central Asia, Europe, and the Middle East.
-->
Dual-Core Expertise
• Medical Devices: PCI products (drug-eluting stents, CTO catheters) with 30+ patents, CE/MDR certified. • IVD Ecosystem: 99+ self-developed biochemical reagents (liver/kidney panels, cardiac markers) and OEM services.
Strategic Infrastructure
• 20,000m² Industrial Park: Features GSP-compliant cold storage (2,500m³), R&D labs, and a Khorgos SEZ-based logistics hub for Belt & Road markets. • Annual Capacity: 5M+ medical devices, 10M+ reagent kits.
Global Footprint
• 150+ healthcare partners across 15 countries, including Central Asia and the EU. • Joint ventures with Hefu Group (IVD distribution) and state-owned trade platforms.
Development History
1995
2016
2019
2021
2022
2023
Established in Urumqi, Xinjiang, laying the groundwork as a specialized producer of high-quality in-vitro diagnostic (IVD) reagents.
Marked a major expansion with a 70 Million RMB investment to establish the state-of-the-art Likang Xiangyun Biotech Park, consolidating R&D, manufacturing, and logistics under one roof.
Achieved a critical R&D breakthrough with the launch of our first self-developed core raw material, patented antigen LK-0001, demonstrating our growing innovation capability.
Successfully obtained CE Marking and MDR certification for our portfolio of Percutaneous Coronary Intervention (PCI) products, including drug-eluting stents and catheters, granting us access to the stringent European market.
Solidified our international presence, growing our network to serve 150+ healthcare partners across 15 countries, from Central Asia to the EU.
Successfully expanded our service model to include comprehensive SPD (Supply, Processing, and Distribution) services for medical materials, which has grown to generate 5 Billion RMB in annual revenue.
Our Team
With rapid growth and in alignment with China’s healthcare reforms, Likang has expanded from midstream distribution to upstream production, establishing Xinjiang Likang Xiangyun Biotechnology Co., Ltd. in 2016 for IVD reagent packaging and manufacturing, with dedicated R&D facilities currently under development.
注: 建议上传图片大小690px*460px
Core Service Advantages
Likang Xiangyun Biotechnology stands at the forefront of the medical industry by combining cutting-edge technology, rigorous quality control, and unparalleled customer support. Our commitment to excellence ensures that every partner receives superior products, reliable service, and long-term success.
Premium-Quality Products – Engineered for Superior Performance
Full traceability from raw materials to finished products.
▪ Cold Chain Logistics:
Temperature-monitored storage (2,500m³ refrigerated capacity) and shipping.
Comprehensive After-Sales Support – Your Success, Our Priority
Dedicated Technical Assistance
▪ 24/7 Hotline: Immediate support for device troubleshooting (+86 991 481 0521 ext. 811).
▪ On-Site Training:
▪ PCI Workshops: Hands-on coaching for interventional cardiology teams.
▪ IVD Lab Setup: Reagent handling, calibration, and QA protocols.
Warranty & Replacement Policies
▪ Device Lifetime Support: Free software/firmware upgrades for diagnostic equipment. 1-year warranty on all PCI devices, extendable to 3 years for bulk orders.
注: 建议上传图片大小690px*460px 
